The Biological Functions of the SART-1 Family in Differentiation and Carcinogenicity of Adenocarcinomas
SART-1家族在腺癌分化和致癌性中的生物学功能
基本信息
- 批准号:10670521
- 负责人:
- 金额:$ 2.18万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Molecules involved in regulation of cellular proliferation at the G2/M phase have not yet been fully identified. This study investigated the involvement of a recently identified SART-1ィイD2800ィエD2. Protein demonstrated an ability to bind to DNA, and accumulated in the nucleus when the cells were arrested at G2/M phase.(l) The localization of SART-1 protein was suggested to be in nucleus of eukaryote cells including monkey kidney EBV-transformed Cos 7 cell and human esophageal cancer TE9 cell when the fusion gene with GFP was transfected and observed by conforcal laser microscopy.(2) SART-1ィイD2800ィエD2 protein is suggested to be a DNA-binding protein by the affinity chromatography of cell lysates of the 293T cells transfected with the HAN/SART-1ィイD2800ィエD2 gene.(3) Transfection of SART-1 gene induced the G2/M-arrest and suppressed the cell growth of all the cell tested. Furthermore, DNA ladder formation was observed in the SART-1 transfected COS-7 and human cancer cells. The transfection of SART-1 up-regulated the nuclear expression of cyclin B and cdc2, well known components of maturation-promoting factor.(4) Several candidate genes which encode proteins that had interacted with SART-1 protein were isolated by two-hybrid system.(5) Three different SART-1 probe protein (N-terminal, middle and C-terminal regions) for far-western blot analysis of SART-1 binding protein candidate obtained by two hybrid system were prepared.(6) We found that murine SART-1 genomic DNA suggested to be consist of 20 exsons. The sequence of the gene will submit to GenBank.(7) SART-1 gene was suggested to be expressed in early development of mouse embryo (l4 days) by northern blot analysis.(8) Several family genes of SART-1 were suggested by northern blot analysis. One of the gene with 3.3kb consist of approximately l488 bp of 5'-region was identical to SART-1 and encoded a protein with 483 amino acid.
参与G2/M期细胞增殖调控的分子尚未完全确定。这项研究调查了最近发现的SART-1突变体D2800突变体D2的参与。蛋白质具有与DNA结合的能力,当细胞被阻滞在G2/M期时,蛋白质在细胞核中积累。(l)将SART-1与GFP融合基因转染到猴肾EBV转化的Cos 7细胞和人食管癌TE 9细胞中,激光共聚焦显微镜观察到SART-1蛋白定位于细胞核内。(2)通过对转染HAN/SART-1拟南芥D2800拟南芥D2基因的293 T细胞的细胞裂解物进行亲和层析,表明SART-1拟南芥D2800拟南芥D2蛋白是DNA结合蛋白。(3)转染SART-1基因的细胞均出现G2/M期阻滞,生长受到抑制。此外,在SART-1转染的COS-7和人癌细胞中观察到DNA梯状条带形成。SART-1的转染上调了细胞周期蛋白B和cdc 2的核表达,这是成熟促进因子的众所周知的组分。(4)利用双杂交技术分离了几个与SART-1蛋白互作的候选基因。(5)制备了三种不同的SART-1探针蛋白(N-末端、中间和C-末端区域),用于对通过双杂交系统获得的SART-1结合蛋白候选物进行远蛋白质印迹分析。(6)我们发现小鼠SART-1基因组DNA由20个外显子组成。该基因的序列将提交给GenBank。(7)北方印迹分析表明SART-1基因在小鼠胚胎早期(14天)表达。(8)通过北方杂交分析,推测了SART-1的几个家族基因。其中一个基因长3.3kb,5 ′端约1488 bp,与SART-1基因完全相同,编码483个氨基酸。
项目成果
期刊论文数量(32)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nakao M, Shichijo S, Imaizumi T, Inoue Y, Matsunaga K, Yamada A, Kikuchi M, Tsuda N, Ohta K, Takamori S, Yamana H, Fujita H and Itoh K: "Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL."J. Immunol.. 164. 256
Nakao M、Shichijo S、Imaizumi T、Inoue Y、Matsunaga K、Yamada A、Kikuchi M、Tsuda N、Ohta K、Takamori S、Yamana H、Fujita H 和 Itoh K:“鉴定编码新鳞状细胞的基因
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shigeki Shichijo: "A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes."Journal of Experimental Medicine. 187. 277-278 (1998)
Shigeki Shichijo:“编码人类鳞状细胞癌抗原肽的基因,可被细胞毒性 T 淋巴细胞识别。”实验医学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kyogo Itoh: "Cell Therapy"Springer-Verlag Tokyo (in press). (1999)
伊藤京吾:“细胞疗法”Springer-Verlag Tokyo(印刷中)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shichijo S, Nakao M, Imai Y,Takasu H, Kawamoto M, Niiya F, Yang D, Toh Y, Yamana H and ltoh K: "A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes."J. Exp. Med.. 187. 277-288 (1998)
Shichijo S、Nakao M、Imai Y、Takasu H、Kawamoto M、Niiya F、Yang D、Toh Y、Yamana H 和 ltoh K:“编码细胞毒性 T 淋巴细胞识别的人类鳞状细胞癌抗原肽的基因。”J.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Toshihiro Imaizumi: "Expression of the tumor-rejection antigen SART1 in brain tumors."International Journal of Cancer. 83. 760-764 (1999)
Toshihiro Imaizumi:“肿瘤排斥抗原 SART1 在脑肿瘤中的表达。”国际癌症杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHICHIJO Shigeki其他文献
SHICHIJO Shigeki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHICHIJO Shigeki', 18)}}的其他基金
Detection of IgG antibody reactive to a p53-derived peptide with HLA-A4601 binding motif in breast cancer patients
检测乳腺癌患者中与带有 HLA-A4601 结合基序的 p53 衍生肽有反应的 IgG 抗体
- 批准号:
16591281 - 财政年份:2004
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of a cluster of tumor antigens recognized by CTh of colon cancer patients
结肠癌患者 CTh 识别的一组肿瘤抗原的鉴定
- 批准号:
14570526 - 财政年份:2002
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Basic study of tumor-vaccine for metastatic epithelial cancer.
转移性上皮癌肿瘤疫苗的基础研究。
- 批准号:
12670533 - 财政年份:2000
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Expression of MAGE tumor rejection antigen on lung cancer and application for cancer vaccine
MAGE肿瘤排斥抗原在肺癌中的表达及其在癌症疫苗中的应用
- 批准号:
07671491 - 财政年份:1995
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Targeting pathogenic TAR DNA-binding protein 43 to treat frontotemporal dementia and motor neuron disease
靶向致病性 TAR DNA 结合蛋白 43 治疗额颞叶痴呆和运动神经元疾病
- 批准号:
nhmrc : 2001572 - 财政年份:2021
- 资助金额:
$ 2.18万 - 项目类别:
Ideas Grants
Electron microscopic analysis of a G4 DNA-binding protein Rif1, a key organizer of chromosomal domains
G4 DNA 结合蛋白 Rif1(染色体结构域的关键组织者)的电子显微镜分析
- 批准号:
18K06102 - 财政年份:2018
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Functional analysis of methylated DNA-binding protein CIBZ in mouse embryogenesis
甲基化DNA结合蛋白CIBZ在小鼠胚胎发生中的功能分析
- 批准号:
16K08587 - 财政年份:2016
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Continuous directed evolution of a light-controlled DNA-binding protein
光控DNA结合蛋白的连续定向进化
- 批准号:
437922-2013 - 财政年份:2015
- 资助金额:
$ 2.18万 - 项目类别:
Postgraduate Scholarships - Doctoral
Function and evolution of mitochondrial DNA-binding protein in the fission yeast
裂殖酵母线粒体DNA结合蛋白的功能和进化
- 批准号:
15K07168 - 财政年份:2015
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a photo-controlled DNA-binding protein
光控 DNA 结合蛋白的开发
- 批准号:
459937-2014 - 财政年份:2015
- 资助金额:
$ 2.18万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Functional analysis of the single-stranded DNA-binding protein FUBP1 as a transcriptional regulator of hematopoietic stem cell self-renewal
单链DNA结合蛋白FUBP1作为造血干细胞自我更新转录调节因子的功能分析
- 批准号:
276833671 - 财政年份:2015
- 资助金额:
$ 2.18万 - 项目类别:
Research Grants
Continuous directed evolution of a light-controlled DNA-binding protein
光控DNA结合蛋白的连续定向进化
- 批准号:
437922-2013 - 财政年份:2014
- 资助金额:
$ 2.18万 - 项目类别:
Postgraduate Scholarships - Doctoral
Structural ans functional analysis of single-stranded DNA-binding protein DdrA
单链 DNA 结合蛋白 DdrA 的结构和功能分析
- 批准号:
26506030 - 财政年份:2014
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a photo-controlled DNA-binding protein
光控 DNA 结合蛋白的开发
- 批准号:
459937-2014 - 财政年份:2014
- 资助金额:
$ 2.18万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral